Researchers discover new potential antibody treatment for asthma

May 20, 2014

Researchers at St. Joseph's Healthcare Hamilton and McMaster University have successfully tested an antibody that can improve the quality of life for individuals with asthma by relieving inflammation in the lungs. The research was led by Dr. Gail Gauvreau, associate professor at McMaster University and Dr. Paul O'Byrne, executive director of the Firestone Institute of Respiratory Health (FIRH) at St. Joseph's Healthcare Hamilton and chair, Department of Medicine at McMaster University.

The study was published in the New England Journal of Medicine and presented at the American Thoracic Society conference in San Diego. It concluded that blocking a specific protein in the lungs with an antibody both alleviates baseline inflammation and provides resistance to allergens for those with mild .

"It was known that the epithelial cells which line the airways in the lungs produce a protein called thymic stromal lymphopoietin (TSLP) that causes inflammation. This study, for the first time, proved that these cells continually produce this protein in humans with asthma," states O'Byrne. "While we studied patients with allergic asthma, this research opens the door for the development of new treatments not only for this population, but for those diagnosed with severe asthma as well."

Individuals with allergic asthma are typically treated with inhaled corticosteroids or bronchodilators that help to control their asthma when taken regularly. While antibodies are typically reserved for , this research can lead to antibody treatment for those who have mild allergic asthma. This study can lead to quality of life improvements for those with allergic asthma that have issues with inhalers or steroid-based medications.

The study – conducted by the Clinical Investigator Collaborative, a multi-centre, Phase II clinical trials group supported by the Allergy, Genes and Environment Network (AllerGen) – recruited 31 patients over five sites across Canada. After 12 weeks of participant monitoring, the antibodies significantly reduced baseline inflammation and protected the participants against inhaled allergens when compared to a placebo.

Established by AllerGen in 2005, the Clinical Investigator Collaborative is globally unique in its ability to undertake early stage clinical trials to evaluate the efficacy of new molecules and compounds that treat inflammation in the lung. O'Byrne, along with fellow researchers at the Firestone Institute for Respiratory Health and other Clinical Investigator Collaborative sites, continues to work closely with clinicians and patients in order to uncover the best treatments, medications and procedures which will improve the quality of life for those diagnosed with respiratory illnesses such as , allergies and pulmonary disease.

Explore further: Researchers find new molecule to treat asthma

Related Stories

Researchers find new molecule to treat asthma

May 12, 2014

A new study carried out by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), the Max Planck Institute for Colloids and Interfaces (Germany), the Free University of Berlin (Germany), UC San Diego, ...

Holiday health: Asthma with a side of allergies

November 8, 2013

People with asthma traveling to pet friendly homes for the holidays may want to pack allergy medication along with their inhaler. A study being presented this week at the American College of Allergy, Asthma and Immunology's ...

Fighting asthma drug resistance

January 10, 2014

Current asthma treatments include drugs that open up the tubes of the lungs and corticosteroids that fight lung inflammation. Some patients, however, are stubbornly resistant to corticosteroids, limiting the therapies available ...

Hope of new treatment for severe asthma patients

October 25, 2013

New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical ...

Recommended for you

Scientists reveal cellular clockwork underlying inflammation

August 27, 2015

Researchers at the Virginia Bioinformatics Institute at Virginia Tech have uncovered key cellular functions that help regulate inflammation—a discovery that could have important implications for the treatment of allergies, ...

New research finds ozone in smog may cause asthma

September 7, 2015

It's completely invisible, but the distinctive smell of electrical discharge after photocopying is a tell-tale sign of ozone in the air. Ozone is a component of what we refer to as 'smog' and on hot sunny days, in cities ...

Severe asthma fails to respond to mainstay treatment

June 29, 2015

The immune response that occurs in patients with severe asthma is markedly different than what occurs in milder forms of the lung condition, according to researchers from the University of Pittsburgh School of Medicine. Those ...

New hope for patients with chronic wounds

June 29, 2015

Most wounds clear up by themselves, but some fail to heal and become chronic. An international team of researchers led from Karolinska Institutet, now unveil the important role of so-called microRNAs in regulating skin wound ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.